Mony U - Search Results

1

Quantitation of mHLA-DR and nCD64 by Flow Cytometry to Study Dysregulated Host Response: The Use of QuantiBRITE™ PE Beads and Its Stability.

Sanju S, Jain P, Priya VV, Varma PK, Mony U. Sanju S, et al. Among authors: mony u. Appl Biochem Biotechnol. 2023 Sep;195(9):5747-5752. doi: 10.1007/s12010-022-03819-6. Epub 2022 Jan 11. Appl Biochem Biotechnol. 2023. PMID: 35015219 Free PMC article.

2

Injectable chitosan-nano bioglass composite hemostatic hydrogel for effective bleeding control.

Sundaram MN, Amirthalingam S, Mony U, Varma PK, Jayakumar R. Sundaram MN, et al. Among authors: mony u. Int J Biol Macromol. 2019 May 15;129:936-943. doi: 10.1016/j.ijbiomac.2019.01.220. Epub 2019 Feb 7. Int J Biol Macromol. 2019. PMID: 30738162

3

Extracellular Trap by Blood Cells: Clinical Implications.

Nija RJ, Sanju S, Sidharthan N, Mony U. Nija RJ, et al. Among authors: mony u. Tissue Eng Regen Med. 2020 Apr;17(2):141-153. doi: 10.1007/s13770-020-00241-z. Epub 2020 Feb 29. Tissue Eng Regen Med. 2020. PMID: 32114678 Free PMC article. Review.

4

Innate lymphoid cells: Potent early mediators of the host immune response during sepsis.

Theertha M, Sanju S, Priya VV, Jain P, Varma PK, Mony U. Theertha M, et al. Among authors: mony u. Cell Mol Immunol. 2020 Oct;17(10):1114-1116. doi: 10.1038/s41423-020-0383-1. Epub 2020 Mar 4. Cell Mol Immunol. 2020. PMID: 32132670 Free PMC article. No abstract available.

5

Vasoconstrictor and coagulation activator entrapped chitosan based composite hydrogel for rapid bleeding control.

Sundaram MN, Mony U, Varma PK, Rangasamy J. Sundaram MN, et al. Among authors: mony u. Carbohydr Polym. 2021 Apr 15;258:117634. doi: 10.1016/j.carbpol.2021.117634. Epub 2021 Jan 19. Carbohydr Polym. 2021. PMID: 33593536

6

Non-classical monocytes and its potential in diagnosing sepsis post cardiac surgery.

Sebastian A, Sanju S, Jain P, Priya VV, Varma PK, Mony U. Sebastian A, et al. Among authors: mony u. Int Immunopharmacol. 2021 Oct;99:108037. doi: 10.1016/j.intimp.2021.108037. Epub 2021 Aug 10. Int Immunopharmacol. 2021. PMID: 34426113

7

Role of myeloid derived suppressor cells in sepsis.

Malavika M, Sanju S, Poorna MR, Vishnu Priya V, Sidharthan N, Varma P, Mony U. Malavika M, et al. Among authors: mony u. Int Immunopharmacol. 2022 Mar;104:108452. doi: 10.1016/j.intimp.2021.108452. Epub 2022 Jan 4. Int Immunopharmacol. 2022. PMID: 34996010 Review.

8

Polysaccharide-Drug Conjugates: A Tool for Enhanced Cancer Therapy.

Yadav N, Francis AP, Priya VV, Patil S, Mustaq S, Khan SS, Alzahrani KJ, Banjer HJ, Mohan SK, Mony U, Rajagopalan R. Yadav N, et al. Among authors: mony u. Polymers (Basel). 2022 Feb 27;14(5):950. doi: 10.3390/polym14050950. Polymers (Basel). 2022. PMID: 35267773 Free PMC article. Review.

9

Role of nanofibrous poly(caprolactone) scaffolds in human mesenchymal stem cell attachment and spreading for in vitro bone tissue engineering--response to osteogenic regulators.

Binulal NS, Deepthy M, Selvamurugan N, Shalumon KT, Suja S, Mony U, Jayakumar R, Nair SV. Binulal NS, et al. Among authors: mony u. Tissue Eng Part A. 2010 Feb;16(2):393-404. doi: 10.1089/ten.TEA.2009.0242. Tissue Eng Part A. 2010. PMID: 19772455

10

Embedded silica nanoparticles in poly(caprolactone) nanofibrous scaffolds enhanced osteogenic potential for bone tissue engineering.

Ganesh N, Jayakumar R, Koyakutty M, Mony U, Nair SV. Ganesh N, et al. Among authors: mony u. Tissue Eng Part A. 2012 Sep;18(17-18):1867-81. doi: 10.1089/ten.TEA.2012.0167. Tissue Eng Part A. 2012. Retraction in: Tissue Eng Part A. 2019 Apr;25(7-8):677. doi: 10.1089/ten.tea.2012.0167.retract. PMID: 22725098 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page